Prostate Neoplasms Unknown Status Phase 2 Trials for Degarelix (DB06699)

Also known as: Neoplasm, Prostate / Neoplasms, Prostate / Prostate Neoplasm

IndicationStatusPhase
DBCOND0031071 (Prostate Neoplasms)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01630967Efficacy Study of Switching to a Lutenizing Hormone-releasing Hormone (LHRH) Antagonist From a LHRH Agonist to Treat Progressive Castrate Resistant Prostate Cancer (CRPC)Treatment